Aromatase inhibitors, arthralgias, and exercise in breast cancer survivors

被引:0
|
作者
Irwin, Melinda
Cartmel, Brenda
Ercolano, Elizabeth
Fiellin, Martha
Rothbard, Marianna
Capozza, Scott
Zhou, Yang
Schmitz, Kathryn
Ligibel, Jennifer A.
Hershman, Dawn L.
Neogi, Tuhina
Gross, Cary P.
机构
[1] Yale Univ, New Haven, CT USA
[2] Yale Univ, Sch Publ Hlth, New Haven, CT USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Columbia Univ, Med Ctr, New York, NY USA
[6] Boston Univ, Boston, MA 02215 USA
[7] Yale Univ, Sch Med, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS669
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time
    Shaaban, Adnan
    Petersen, Ashley
    Beckwith, Heather
    Florea, Natalia
    Potter, David A.
    Yee, Douglas
    Vogel, Rachel I.
    Duprez, Daniel
    Blaes, Anne H.
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [32] Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors
    Breckenridge, Lynn M.
    Bruns, Gina L.
    Todd, Briana L.
    Feuerstein, Michael
    PSYCHO-ONCOLOGY, 2012, 21 (01) : 43 - 53
  • [33] Endothelial dysfunction in breast cancer survivors on aromatase inhibitors (AIs) over time
    Blaes, A. H.
    Petersen, A.
    Beckwith, H.
    Potter, D.
    Florea, N.
    Yee, D.
    Vogel, R.
    Duprez, D.
    CANCER RESEARCH, 2019, 79 (04)
  • [34] Efficacy of antiobesity medications among breast cancer survivors taking aromatase inhibitors
    Fansa, Sima
    Ghusn, Wissam
    Tama, Elif
    Nicolalde, Bryan
    Anazco, Diego
    Andre, Stacy D. '
    Faubion, Stephanie S.
    Shufelt, Chrisandra L.
    Acosta, Andres
    Andrade, Maria D. Hurtado
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (03) : 553 - 563
  • [35] Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors
    Mao, Huijuan
    Bao, Ting
    Shen, Xueyong
    Li, Qing
    Seluzicki, Christina
    Im, Eun-Ok
    Mao, Jun J.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 47 - 54
  • [36] Prevalence and Risk Factors for Insomnia in Breast Cancer Survivors Receiving Aromatase Inhibitors
    Mao, J. J.
    Gehrman, P. R.
    Su, I. H.
    Bruner, D. W.
    Xie, S. X.
    El Sehamy, A.
    DeMichele, A. M.
    CANCER RESEARCH, 2009, 69 (24) : 558S - 558S
  • [37] Perceptions of breast cancer and experience of side-effects by breast cancer survivors prescribed tamoxifen and aromatase inhibitors
    Hughes, Lyndsay
    Moss-Morris, Rona
    Hunter, Myra
    Norton, Sam
    Moon, Zoe
    PSYCHO-ONCOLOGY, 2020, 29 : 8 - 8
  • [38] Perceptions of breast cancer and experience of side-effects by breast cancer survivors prescribed tamoxifen and aromatase inhibitors
    Hughes, Lyndsay
    Moss-Morris, Rona
    Hunter, Myra
    Norton, Sam
    Moon, Zoe
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2021, 28 (SUPPL 1) : S143 - S143
  • [39] Randomized Exercise Trial of Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors
    Irwin, Melinda L.
    Cartmel, Brenda
    Gross, Cary P.
    Ercolano, Elizabeth
    Li, Fangyong
    Yao, Xiaopan
    Fiellin, Martha
    Capozza, Scott
    Rothbard, Marianna
    Zhou, Yang
    Harrigan, Maura
    Sanft, Tara
    Schmitz, Kathryn
    Neogi, Tuhina
    Hershman, Dawn
    Ligibel, Jennifer
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (10) : 1104 - 1111
  • [40] SEXUAL ASSESSMENT IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS: ARE THEY INTERESTED ON SEXOLOGY CONSULTATION?
    Angles-Acedo, S.
    Ribera-Torres, L.
    Mension, E.
    Gomez Carballo, S.
    Tortajada, M.
    Matas, I
    Alonso, I
    Castelo-Branco, C.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S170 - S171